Valion Bio Inc.
VBIO | NASDAQ
$0.52
-$0.03 (-5.45%)
Nov 2, 2026, 2:30 PM ET · Market open
Fiscal Year Period Ending | FY 2026 Dec 31, 2025 | FY 2025 Dec 31, 2024 | FY 2024 Dec 31, 2023 | FY 2023 Dec 31, 2022 | FY 2022 Dec 31, 2021 | FY 2021 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Net Income | -7.99M | -4.47M | -8.24M | -10.1M | -8.49M | -3.64M |
Depreciation & Amortization | 5K | 352K | 182K | 174K | 24K | 8K |
Stock-Based Compensation | 564K | 229K | 271K | 398K | n/a | n/a |
Other Working Capital | 313K | -793K | -150K | 504K | -575K | -109K |
Other Non-Cash Items | -27K | -643K | 32K | n/a | 3.26M | 560K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 452K | -1.19M | -752K | 605K | -403K | 44K |
Operating Cash Flow | -7M | -5.73M | -8.51M | -8.92M | -5.61M | -3.03M |
Capital Expenditures | -38K | n/a | -118K | -11K | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -124K | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -543K | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -705K | n/a | -118K | -11K | n/a | n/a |
Debt Repayment | -172K | n/a | n/a | n/a | 2.59M | 1.75M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -27K | -49K | n/a | -528K | n/a | n/a |
Financial Cash Flow | 18.35M | 4.33M | 8.51M | -528K | 17.54M | 1.76M |
Net Cash Flow | 10.64M | -1.39M | -122K | -9.46M | 11.93M | -1.27M |
Free Cash Flow | -7.04M | -5.73M | -8.63M | -8.93M | -5.61M | -3.03M |
Adj. Free Cash Flow | -7.6M | -5.95M | -8.9M | -9.33M | -5.61M | -3.03M |
Maintenance CapEx | -38K | n/a | -118K | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | -11K | n/a | n/a |
Owner Earnings | -7.04M | -5.73M | -8.63M | -8.92M | -5.61M | -3.03M |
Add to Watchlist
Select watchlists to add or remove VBIO